ALXA Financial Facts
Net loss attributable to Alexza common stockholders: -3.02MTotal operating expenses: 10.66M
See Full Income Statement
See Full Balance Sheet
Alexza Pharmaceuticals Inc. (ALXA) Earnings
|
Expand Research on ALXA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +40.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -9.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
5/11/16  |
 |
Q116 | -$0.16 | N/A | N/A | N/A | N/A | N/A |  | | Details |
| 3/28/16 |
|
Q415 | -$0.15 | N/A | N/A | $673K | $1.45M | N/A | | | Details |
| 8/6/15 |
|
Q215 | -$0.63 | -$0.60 | -$0.03 | N/A | $1.49M | N/A | | | Details |
| 3/9/15 |
|
Q414 | -$0.35 | -$0.68 | +$0.33 | $1.45B | $1.3M | N/A | | | Details |
| 11/5/15 |
|
Q315 | -$0.27 | -$0.34 | +$0.07 | $1.77M | $1.6M | N/A | | | Details |
| 8/7/14 | Q214 | -$0.34 | -$0.67 | +$0.33 | $1.5M | $2.24M | N/A | | | Details | |
| 5/6/15 |
|
Q115 | -$0.02 | -$0.51 | +$0.49 | $705K | $3.36M | N/A | | | Details |
| 8/8/11 |
|
Q211 | -$0.13 | -$0.15 | +$0.02 | $1.26M | $430K | N/A | | | Details |
